Mozobil
Active Ingredient(s): PlerixaforFDA Approved: * December 15, 2008
Pharm Company: * GENZYME
Category: Cancer
Plerixafor (INN and USAN, trade name Mozobil) is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients into the bloodstream. The stem cells are then extracted from the blood and transplanted back to the patient. The drug was developed by AnorMED, which was subsequently bought by Genzyme. Contents 1 Medical uses 2 Contraindications 2.1 Pregnancy and lactation 3 Adverse effects 4 Interactions 5 Pharmacology 5.1 Mechanism of action 5.2 Pharmacokinetics 6 Chemist... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.1 Discussion